Regardless of the mechanism for their development, the lack of specificity of these clonally expanded LGL cells for RA or LGL leukemia suggests that anti-TNF inhibitor therapy is not likely to be the mechanistic link between RA and T-LGL leukemia. The gene discussed is TNF; the disease is rheumatoid arthritis.